Scannell Timothy J
SEC CIK 1451533 · EDGAR
BoughtSold
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:26 | 2026-06-03 | NVCR | NovoCure Ltd | Scannell Timothy J | Dir | A - Grant | $0.00 | +11.6K | 25.9K | +81% | $0 |
| 2026-06-03 16:53 | 2026-06-02 | NVCR | NovoCure Ltd | Scannell Timothy J | Dir | S - Sale | $15.77 | -2,945 | 14.3K | -17% | -$46.4K | |
| 2026-05-21 16:37 | 2026-05-20 | PODD | Insulet Corporation | Scannell Timothy J | Dir | A - Grant | $0.00 | +1,660 | 33.0K | +5% | $0 | |
| D | 2025-06-06 | 2025-06-04 | NVCR | NovoCure Ltd | Scannell Timothy J | Dir | A - Grant | $0.00 | +11.2K | 17.2K | +186% | $0 |
| 2025-06-04 | 2025-06-03 | NVCR | NovoCure Ltd | Scannell Timothy J | Dir | S - Sale | $17.32 | -999 | 6,018 | -14% | -$17.3K | |
| 2025-05-27 | 2025-05-22 | PODD | Insulet Corporation | Scannell Timothy J | Dir | A - Grant | $0.00 | +778 | 31.4K | +3% | $0 | |
| 2024-09-11 | 2024-09-10 | PODD | Insulet Corporation | Scannell Timothy J | Dir | S - Sale | $225.84 | -5,000 | 30.6K | -14% | -$1.13M | |
| 2024-06-11 | 2024-06-10 | PODD | Insulet Corporation | Scannell Timothy J | Dir | S - Sale | $190.51 | -7,000 | 35.6K | -16% | -$1.33M | |
| D | 2024-06-06 | 2024-06-05 | NVCR | NovoCure Ltd | Scannell Timothy J | Dir | A - Grant | $0.00 | +4,053 | 7,981 | +103% | $0 |
| D | 2024-06-06 | 2024-06-04 | NVCR | NovoCure Ltd | Scannell Timothy J | Dir | S - Sale | $23.89 | -964 | 2,964 | -25% | -$23.0K |
| D | 2024-05-29 | 2024-05-28 | PODD | Insulet Corporation | Scannell Timothy J | Dir | S - Sale+OE | $180.90 | -3,300 | 42.6K | -7% | -$597.0K |
| DM | 2024-05-29 | 2024-05-28 | PODD | Insulet Corporation | Scannell Timothy J | Dir | M - OptEx | $32.33 | +18.3K | 37.1K | +97% | +$590.6K |
| 2024-05-23 | 2024-05-22 | PODD | Insulet Corporation | Scannell Timothy J | Dir | A - Grant | $0.00 | +1,380 | 27.6K | +5% | $0 | |
| D | 2023-06-09 | 2023-06-07 | NVCR | NovoCure Ltd | Scannell Timothy J | Dir | A - Grant | $0.00 | +3,853 | 3,928 | +5,137% | $0 |
| 2023-05-24 | 2023-05-23 | PODD | Insulet Corporation | Scannell Timothy J | Dir | A - Grant | $0.00 | +843 | 26.2K | +3% | $0 | |
| 2022-05-26 | 2022-05-24 | PODD | Insulet Corporation | Scannell Timothy J | Dir | A - Grant | $0.00 | +1,009 | 25.4K | +4% | $0 | |
| D | 2021-08-03 | 2021-08-01 | SYK | Stryker Corporation | Scannell Timothy J | Pres, COO | F - Tax | $270.94 | -1,872 | 219.7K | -0.8% | -$507.2K |
| D | 2021-08-03 | 2021-08-01 | SYK | Stryker Corporation | Scannell Timothy J | Pres, COO | M - OptEx | $0.00 | +3,659 | 221.6K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations